SCHEMBL13313611

SCHEMBL13313611

CCSC(C)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9775068 0.81 ALDH1A1 (0.42)
SCHEMBL13348564 0.79
SCHEMBL20299956 0.78 CA1 (0.39)
SCHEMBL5276974 0.77 SMN1; SMN2 (0.46)
SCHEMBL27437096 0.77 TSHR (0.42)
SCHEMBL7110571 0.76 EPHX1 (0.62)
SCHEMBL5638166 0.74 CA1 (0.36)
SCHEMBL7198010 0.74 SMN1; SMN2 (0.39)
SCHEMBL112203 0.74 ALDH1A1 (0.48)
SCHEMBL283731 0.74 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137401-A1 2-METHYLPROP ANAMIDES AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2010-06-03 US disclosed
US-7687665-B2 2-(4-Chlorophenyl)-N-[(1R,2R)-2-(benzyloxy)cyclohexyl]-2-methylpropanamide; modulators of 11- beta hydroxyl steroid dehydrogenase type 1 and/or mineralocorticoid receptor INCYTE CORPORATION (US) 2010-03-30 US disclosed